t-9

T9 peptide (SKTFNTHPQSTP) 是一种特定肌肉靶向的肽.它与 C2C12 成肌细胞具有高度结合能力.当T9 peptide 与寡核苷酸结合时,其对心脏和股四头肌的靶向特异性得到增强,但对肾、肝和膈肌的靶向作用不明显.

ABT-963 是一种高效和选择性的二取代哒嗪酮环氧合酶-2（LOX2）抑制剂，剂量依赖性地降低卡拉胶痛觉过敏模型中的伤害感受。ABT-963 可用于研究关节炎。

T-900607是一种新型微管蛋白活性剂，通过独特的作用机制破坏微管聚合。t-900607具有心脏毒性。

CU-CPT-9a 是TLR8特异性拮抗剂，IC50值为 0.5 nM。

IT-901 是一种具有口服活性和有效性的 NF-κB 亚基 c-Rel 抑制剂，对 NF-κB 和 c-Rel 与 DNA 结合的 IC50 分别为 0.1 µM 和 3 μM。IT-901 是一种具有抗肿瘤活性的萘硫代巴比妥酸酯衍生物，可用于预防和治疗人类淋巴瘤和骨髓瘤。

BEBT-908 (PI3Kα inhibitor 1) 是一种选择性的PI3Kα抑制剂(IC50<0.1 μM)，也抑制 HDAC (0.1 μM≤IC50≤1 μM)。

MRT-92 是一种针对Smoothened(Smo)的拮抗剂，具备抗癌特性 (Ki=0.7 nM)。其作用机理主要是通过阻断Smoothened受体跨膜域的重叠结合位点，抑制Hedgehog信号通路，进而影响啮齿动物小脑颗粒细胞的增殖 (IC50=0.4 nM)。该化合物广泛应用于小脑神经胶质瘤的科研领域。

OBPt-9 是促进俄雷西定受体活性的化合物，其作用主要表现在提升俄雷西定信号的调节上。

NCTT-956 是一种高效且特异性的血小板 12-脂氧合酶 (12-LOX) 活性抑制剂。

AT-9283 L-lactate is an inhibitor of aurora kinase.

IT-9302 is a synthetic agonist of interleukin-10.

AT-9283, a multi-targeted kinase inhibitor, is used potentially for the treatment of multiple myeloma.

ABT-925 is a selective dopamine D3 receptor (DRD3) antagonist with an in vitro affinity approximately 100 times higher for dopamine D3 receptors than for D2 receptors.

T-91825 (PPI-0903M) is a potent N-phosphono-type cephalosporin compound, which serves as the active variant of TAK-599. It exhibits broad-spectrum activity against both gram-positive and gram-negative bacteria [1][2].

AT-9010, a triphosphate derivative of AT-527, exhibits strong inhibitory activity against NiRAN, a crucial viral replication function. This compound effectively suppresses the replication of SARS-CoV-2.

AT-9010 tetrasodium is a triphosphate active metabolite derived from AT-527. It acts as a potent inhibitor of NiRAN, a crucial function for viral replication. Furthermore, AT-9010 tetrasodium demonstrates its ability to effectively inhibit the replication of SARS-CoV-2.

MLT-985 is a highly selective allosteric MALT1 inhibitor with an IC 50 value of 3 nM.

AT-9010 triethylamine, a triphosphate active metabolite of AT-527, is a potent inhibitor of the NiRAN enzyme, which is essential for viral replication. It effectively inhibits SARS-CoV-2 replication.

Antitubercular agent-9 shows effective antitubercular activity with a MIC value of 1.03-2.32 μM.

Antileishmanial agent-9 (compound 16c) exhibits potent and selective activity against Leishmania donovani (L. donovani) with an IC50 value of 4.01 μM. In addition, this compound demonstrates relatively low cytotoxicity in L-6 cells, with an IC50 value of 40.1 μM [1].

Antiparasitic agent-9 (compound 47) is a highly active and orally administered antiparasitic agent, exhibiting potent antiparasitic efficacy against the human parasite [1].

(R)-MLT-985 (compound 11) 是一种 MALT1 蛋白酶的有效抑制剂 (IC50: 3 nM)。(R)-MLT-985 在 Jurkat 细胞中对 MALT1 依赖性 IL-2 的 IC50 值为 20 nM。(R)-MLT-985 对 ABC-DLBCL 细胞中的生长和异常 CARD11 BCL10 MALT1 复合物信号传导具有抑制作用。

ALT-946 free base is an inhibitor of advanced glycation that has been shown to improve severe nephropathy in the diabetic transgenic (mREN-2)27 rat.

ABT-925, also known as A-37203, BSF-201640; DAT-201; Lu-201640; and A-437203, is a selective dopamine D3 receptor (DRD3) antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors. ABT-925 was tested in schizophrenia. ABT-925 is a selective dopamine D₃ receptor antagonist with an approximately 100-fold higher in vitro affinity for dopamine D₃ versus D₂ receptors.